Since 1998, WCCT Global has been conducting clinical research in all phases and across a number of therapeutic areas, with an emphasis in designing and overseeing early clinical development programs. Currently, WCCT owns and operates one of the largest Phase 1 clinical pharmacology units in the United States, and is an industry-leader in conducting Asian bridging studies, specifically in Japanese volunteers, aiding the development of treatments for the global drug market. In addition to running Phase 1 trials in healthy volunteers and Asian bridging studies, WCCT offers a full suite of contract research and clinical support services, and is the only US-based clinical research organization capable of conducting viral challenge studies at its stateside facility.
Complete your study on time and on budget with WCCT’s comprehensive offerings:
● Specialized CRO services
● Clinical trial recruitment
● Clinical expertise at each level of your study